Organon is an independent global healthcare company with a focus on improving the health of women throughout their lives. The company has a diverse portfolio that covers women's health, biosimilars, and established brands, offering therapies for a wide array of conditions including reproductive health, cardiovascular disease, neurology, autoimmune, and respiratory conditions. Organon is active in over 150 markets worldwide and is committed to delivering medicines and devices that advance women's health at all life stages. Additionally, the company works on biosimilars to provide more accessible treatment options. Organon aims to create a brighter future and better health outcomes for women through its comprehensive healthcare solutions.